Hunan Jingfeng Pharmaceutical

SHE:000908 China Drug Manufacturers - General
Market Cap
$605.52 Million
CN¥4.44 Billion CNY
Market Cap Rank
#14971 Global
#3992 in China
Share Price
CN¥5.05
Change (1 day)
+4.99%
52-Week Range
CN¥3.85 - CN¥9.23
All Time High
CN¥16.99
About

Hunan Jingfeng Pharmaceutical Co.,Ltd. manufactures and sells chemical drugs and biological agents in China. The company's principal product is sodium hyaluronate injection for use in orthopedics and surgery applications. It also offers ophthalmic equipment and API products, as well as engages in the research and development of antitumor, cancer, and cardiovascular drugs; and distributed in the f… Read more

Hunan Jingfeng Pharmaceutical (000908) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: -3.332x

Based on the latest financial reports, Hunan Jingfeng Pharmaceutical (000908) has a cash flow conversion efficiency ratio of -3.332x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥125.78 Million) by net assets (CN¥-37.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Hunan Jingfeng Pharmaceutical - Cash Flow Conversion Efficiency Trend (1999–2024)

This chart illustrates how Hunan Jingfeng Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Hunan Jingfeng Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hunan Jingfeng Pharmaceutical ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Hunan Jingfeng Pharmaceutical (1999–2024)

The table below shows the annual cash flow conversion efficiency of Hunan Jingfeng Pharmaceutical from 1999 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥-15.13 Million CN¥-5.55 Million 0.367x +260.81%
2023-12-31 CN¥-153.68 Million CN¥35.06 Million -0.228x -139.76%
2022-12-31 CN¥214.83 Million CN¥123.27 Million 0.574x +51.85%
2021-12-31 CN¥327.73 Million CN¥123.83 Million 0.378x +188.76%
2020-12-31 CN¥638.18 Million CN¥-271.68 Million -0.426x -2385.47%
2019-12-31 CN¥1.94 Billion CN¥36.17 Million 0.019x -84.81%
2018-12-31 CN¥2.86 Billion CN¥350.94 Million 0.123x +110.21%
2017-12-31 CN¥2.60 Billion CN¥151.65 Million 0.058x +1136.37%
2016-12-31 CN¥2.61 Billion CN¥12.32 Million 0.005x -88.52%
2015-12-31 CN¥2.25 Billion CN¥92.37 Million 0.041x -80.17%
2014-12-31 CN¥994.04 Million CN¥205.93 Million 0.207x +131.95%
2013-12-31 CN¥5.31 Million CN¥-3.44 Million -0.648x -10996.71%
2012-12-31 CN¥-60.15 Million CN¥351.50K -0.006x +99.93%
2011-12-31 CN¥790.82K CN¥-6.87 Million -8.689x -3203.30%
2010-12-31 CN¥57.85 Million CN¥-15.21 Million -0.263x -122.84%
2009-12-31 CN¥100.67 Million CN¥-11.88 Million -0.118x -228.87%
2008-12-31 CN¥338.64 Million CN¥31.02 Million 0.092x -40.95%
2007-12-31 CN¥336.95 Million CN¥52.26 Million 0.155x -9.89%
2006-12-31 CN¥336.40 Million CN¥57.90 Million 0.172x +195.38%
2005-12-31 CN¥329.66 Million CN¥-59.49 Million -0.180x +60.83%
2004-12-31 CN¥339.45 Million CN¥-156.37 Million -0.461x -958.22%
2003-12-31 CN¥419.38 Million CN¥22.51 Million 0.054x +59.52%
2002-12-31 CN¥522.69 Million CN¥17.59 Million 0.034x -45.02%
2001-12-31 CN¥498.41 Million CN¥30.50 Million 0.061x +222.29%
2000-12-31 CN¥500.54 Million CN¥-25.05 Million -0.050x -278.13%
1999-12-31 CN¥485.43 Million CN¥13.64 Million 0.028x --